Doxorubicin and paclitaxel versus fluorouracil, doxorubicin and cyclophosphamide as first-line therapy for women with advanced breast cancer: long-term analysis of the previously published trial.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples